Trademark: 79232578
Word
HYFC TECHNOLOGY
Status Date
Tuesday, April 30, 2019
Registration Number
5736165
Registration Date
Tuesday, April 30, 2019
Filing Date
Wednesday, February 28, 2018
Published for Opposition
Tuesday, February 12, 2019
5 Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for preventing and treating obesity; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for wounds; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of infectious diseases; Synthetic peptides for pharmaceutical purposes for treating hypertension; Synthetic peptides for pharmaceutical purposes for the prevention of osteoporosis; Synthetic peptides for pharmaceutical purposes for the treatment of hormonal disorders and the prevention of osteoporosis; Synthetic peptides for pharmaceutical purposes for the treatment of eye diseases and conditions; Synthetic peptides for pharmaceutical purposes for the treatment of multiple sclerosis; Synthetic peptides for pharmaceutical purposes for treating diabetes; Synthetic peptides for pharmaceutical purposes for affecting metabolism; Synthetic peptides for pharmaceutical purposes for regulating the immune system; Synthetic peptides for pharmaceutical purposes for the treatment of viral diseases; Synthetic peptides for pharmaceutical purposes for affecting and treating urogenital organs; Synthetic peptides for pharmaceutical purposes for preventing and treating obesity; Synthetic peptides for pharmaceutical purposes for the treatment of bone diseases; Synthetic peptides for pharmaceutical purposes for wounds; Synthetic peptides for pharmaceutical purposes for activating cellular function; Synthetic peptides for pharmaceutical purposes for affecting digestive organs; Synthetic peptides for pharmaceutical purposes for the treatment of cardiovascular disease; Synthetic peptides for pharmaceutical purposes for treating malignant tumours; Synthetic peptides for pharmaceutical purposes for the treatment and prevention of cancer; Synthetic peptides for pharmaceutical purposes for treatment of viral and infectious diseases, for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of auto-immune diseases
Color is not claimed as a feature of the mark.
"TECHNOLOGY"
The mark consists of a stylized design consisting of two ovals connected by 5 lines to two more ovals that are divided, and are stacked above two other ovals. To the right of the stylized design are the letters "hyFc" stacked above the word "technology".
May 28, 2020
New Representative At Ib Received
Sep 13, 2019
Final Decision Transaction Processed By Ib
Aug 24, 2019
Final Disposition Notice Sent To Ib
Aug 24, 2019
Final Disposition Processed
Jul 30, 2019
Final Disposition Notice Created, To Be Sent To Ib
May 13, 2019
Teas Change Of Correspondence Received
Apr 30, 2019
Registered-Principal Register
Feb 12, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 12, 2019
Published For Opposition
Feb 8, 2019
Notification Processed By Ib
Jan 23, 2019
Notification Of Possible Opposition Sent To Ib
Jan 23, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 23, 2019
Notification Of Notice Of Publication E-Mailed
Dec 27, 2018
Teas Change Of Correspondence Received
Dec 28, 2018
Approved For Pub - Principal Register
Dec 27, 2018
Teas/Email Correspondence Entered
Dec 27, 2018
Correspondence Received In Law Office
Dec 27, 2018
Teas Response To Office Action Received
Jul 14, 2018
Refusal Processed By Ib
Jun 28, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Jun 28, 2018
Refusal Processed By Mpu
Jun 20, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Jun 19, 2018
Non-Final Action Written
Jun 12, 2018
Assigned To Examiner
Jun 5, 2018
Application Filing Receipt Mailed
Jun 1, 2018
New Application Office Supplied Data Entered In Tram
May 24, 2018
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
